ALYACEN 1/35
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for ALYACEN 1/35, covering 2012-01-19 to 2020-07-06. Get the full timeline:
Most recent: FDA Approved: ALYACEN 1/35 — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)